Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Olivia Aline Furstoss has worked on the following 15 EPO patent applications which have been published in the last five years:

EP10799189

HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/4745, A61K 31/7004, A61K 31/717
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
PATENT GRANTED
EP11738415

PROCESS FOR REMOVING ADVENTITIOUS AGENTS DURING THE PRODUCTION OF A VIRUS IN CELL CULTURE

IPC classification:
C12N 7/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13708142

IMMUNOLOGICALLY USEFUL ARGININE SALTS

IPC classification:
A61K 31/4375, A61P 37/04, C07D 471/04
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
PATENT GRANTED
EP14758351

LARGE SCALE PRODUCTION OF VIRUSES IN CELL CULTURE

IPC classification:
A61K 39/145, C12N 7/00
Applicant:
The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12704573

ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

IPC classification:
A61K 9/107, A61K 31/4375, A61K 47/26, A61K 47/32, A61K 47/44
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
PATENT GRANTED
EP14789550

CALCIUM FLUORIDE COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14795571

CALCIUM FLUORIDE COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16164271

COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

IPC classification:
A61K 9/16, A61K 39/385, A61K 39/39, A61P 31/04
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15715431

LIPOSOMAL COMPOSITIONS FOR MUCOSAL DELIVERY

IPC classification:
A61K 9/127
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15716137

IMMUNOGENIC LIPOSOMAL FORMULATION

IPC classification:
A61K 9/127, A61K 31/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709964

OIL/SURFACTANT MIXTURES FOR SELF-EMULSIFICATION

IPC classification:
A61K 9/107, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16190246

LIPIDATED OXOADENINE DERIVATIVES

IPC classification:
A61K 31/52, A61K 31/522, A61P 37/04, C07F 9/6561
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15791768

MAMMALIAN CELLS EXPRESSING CYTOMEGALOVIRUS ANTIGENS

IPC classification:
A61K 39/245, C07K 14/005, C12N 5/071
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made
EP15797460

ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS

IPC classification:
A61K 31/522, A61P 31/00, A61P 35/00, A61P 37/08, C07D 473/18
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Olivia Aline Furstoss, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature